Disability Rights and Wrongs

Picture a packed lecture hall in Lancaster, September 2006. The UK Disability Studies Association conference is buzzing, but not with easy agreement. Before Tom Shakespeare has really begun, people are shifting in their seats, Nordic guests are already whispering critiques, and then—after he's uttered about ten sentences—the room finally settles. That mood tells you a lot. Disability studies had grown up with the British social model as its anchor, especially in activist circles, and now one of its own was about to push hard against the frame. The scene is a reminder that no single national model can stand for everyone, and that when ideas travel across countries and movements, they change color in the light. Shakespeare calls himself a "critical friend" of the British social model, and he's earned it. He's been both an activist and a scholar, and that dual identity sets the tone. His claim is blunt: the social model has run into a cul-de-sac. Not because it failed politically—its emancipatory charge is undeniable—but because its success hardened into orthodoxy. As reviews soon after the launch made clear—Sheldon and colleagues in 2007, Simo Vehmas in 2007 and 2008, and later Nordic commentators—he wasn't offering a tidy fix within the old lines. He was challenging the lines themselves, warning that when one approach claims to be the only true one, it starts to police its borders and shrink the questions you're allowed to ask. At the heart of that warning is a problem with dichotomies. Social versus medical explanations. Disability versus impairment. Disabled versus non-disabled people. Shakespeare argues these splits look clean on paper but crumble under inspection. Start with the so-called medical model. He points out there's little evidence of a single, coherent "medical model" developed by medicine itself. It often serves as a foil—something proponents of the social model invoke to define what they're not. And then comes the tautology risk: if you define disability as social by definition—because disabling barriers are what count—then biology becomes irrelevant by fiat. That's tidy theory. It's terrible empiricism. In Britain, he argues, that tidiness drifted into inflexibility, discouraging inquiry that didn't fit the script and, by extension, steering policy toward what the script already knew. To frame this, Shakespeare borrows from the philosophy of science. Think of Thomas Kuhn's picture of "normal science" running into anomalies it can't explain, sliding toward a crisis. That's the pressure he sees building. And when he pushes back on pure social constructivism, he leans on Ian Hacking's critique: social realities are real, but they aren't all that's real. Biology isn't just a story we tell; neither is it a brute, context-free fate. The choice isn't "all in your head" or "all in your cells." Reality is messier, layered, and mixed. So what takes the place of the binary? Shakespeare's alternative is an interactionist view: disability as a complex interplay between intrinsic and extrinsic factors. In plain terms, bodies and environments shape each other. He asks for thicker descriptions—the kind Charles Taylor urged—because simple models strip away the very texture that does the causal work. If you adopt a bio-psycho-social lens, you're not hedging. You're acknowledging that impairments can matter without reducing people into medicalization, and that social barriers can be decisive without pretending bodies are interchangeable. That shift opens practical space. It lets policy move past a reflex fight between clinics and curb cuts, and instead design around how they meet in real lives: in care systems, in universal design, in rights claims that know where the ramp ends and the appointment starts. There's a parallel move on identity. Shakespeare distinguishes identity as a political project—asserting rights and building solidarity—from identity as a lived, cognitive, and social process. He draws on Axel Honneth's and Nancy Fraser's debates over recognition and redistribution to make the point: you can't ask a single neat theory to carry scientific explanation and political convenience at the same time. When you do, you tend to flatten people into symbols or, worse, tangle your evidence around your slogans. The payoff of separating the registers is the freedom to build coalitions that keep structural barriers central without denying embodiment, and to talk about impairment effects without sliding into stigma or cure-alls. If you're listening for a turnkey solution, you won't find one. What you get is a reframed problem space. Shakespeare's Parts II and III, as reviewers read them, don't present a new doctrine for bioethics or care. They model how an interactionist lens alters familiar disputes. Start with prenatal screening and end-of-life decisions. The book resists blanket answers—for or against biotechnology—because blanket answers usually miss the person in front of you and the system around them. The proposed stance is care-centric, but not in the sentimental sense. Care is relational, reciprocal, and structured by politics: by who gets paid, who gets respite, and who gets to choose. Fold in genetic and stem-cell therapies, and the same rule applies. Don't sort technologies into moral camps in the abstract. Evaluate them in context—what they enable, what they crowd out, who bears the risk, and who gains the agency. This isn't just British business. The cross-cultural conversation, especially with Nordic scholars, keeps cropping up for a reason. Nordic reviewers tended to emphasize disability as contextual and relational and were less allergic to the language of charity, while still pressing rights claims. That sensibility—rights and care in dialogue, not at war—offers a counterpoint to the British cul-de-sac Shakespeare describes. The Lancaster launch captured that friction in miniature: a social model forged in one political arena hits different ears elsewhere, and the questions sharpen. What counts as empowerment in one welfare regime can feel incomplete, or even perverse, in another. Zoom back to the methodological level for a second. Shakespeare's critical realism isn't an abstract flourish; it's a work plan. Treat social and biological mechanisms as real, operating at different levels, and interacting in specific settings. Then ask how those interactions produce the experiences we label "disability." You can hear the causal nuance in the verbs: constrain, enable, afford, and disable. Once that's your grammar, a lot of stalemates dissolve. You can center access and rights without pretending biology is decoration. You can acknowledge impairment effects without turning to pathology as the master key. And you can write policy that is neither medical by default nor social by decree. Now, the book is not flawless. Kristiansen and Kermit, writing from a Nordic vantage point, call it accessible, relatively inexpensive, and packed with food for thought. They also flag some factual slips and say the referencing could be tighter. Others had similar quibbles: a sense that the volume reads like three smaller books bound together, with seams that occasionally show, and a title—Rights and Wrongs—that risks being read as more doctrinaire than the text really is. None of that sinks the project, but it marks it as provisional and exploratory. Their bottom line is still a warm recommendation, especially for students and researchers in disability studies, perhaps particularly in the Nordic countries. Read it the way it was written—open-mindedly and with a bit of nerve. One more uncomfortable point deserves daylight. The social model's dominance didn't just guide research; it sometimes policed it. Shakespeare, and reviewers like Sheldon and colleagues and Vehmas, warn that defining your framework as the truth can turn into a self-fulfilling prophecy. Novel insights get treated as heresy rather than data. That's the scientific risk. The political risk is subtler: when discourse hardens, it can lock activists and policymakers into scripts that fit yesterday's fights better than today's dilemmas. An interactionist, critical-realist frame doesn't cure that, but it makes it harder to ignore counterevidence and easier to adjust course without calling it betrayal. So where does this leave the day-to-day questions—care, intimacy, friendship—that often get flattened under policy headlines? Here, the interactionist stance directs attention to relationships. Care isn't a private virtue quietly happening in kitchens. It's patterned by labor laws, disability benefits, housing policy, and the cultural stories we tell about dependence and autonomy. Shakespeare's suggestion is to evaluate practices—prenatal counseling, home care funding, and hospice protocols—by how they balance justice and relationship, not by which side of a medical or social binary they sit on. And to assume, going in, that bodies and environments are talking to each other the whole time. If you've been steeped in the British social model, this all may land as a challenge to cherished clarity. Shakespeare would say that's the point. Keep what made the model liberating—its insistence on barrier removal, on rights, and on solidarity. Shed what turned that liberation into a mandate to look away from biology or to caricature medicine as a monolith. The prize is a thicker, more responsive account of disability that makes better science and better politics possible. A brief look forward, and then we'll close. If there's a theme uniting the Lancaster spark, the cross-Channel debate, and the philosophical scaffolding, it's responsiveness—being ready to let new evidence and new contexts reshape settled dogma. That's how fields avoid cul-de-sacs. It's also how movements stay generous without losing their edge. Shakespeare's wager is that disability studies can do both if it trades the false comfort of binaries for the harder work of mapping interactions. And that, perhaps, is why the room in Lancaster went quiet after those first ten sentences. Not because people agreed, but because they recognized the stakes. When a field decides to thicken its descriptions—to let biology and society, recognition and redistribution, care and rights, speak in the same breath—it chooses complexity over slogan. That choice doesn't end debate. It keeps it honest, and it keeps it alive.